Multiple Sclerosis

Latest News

Tau and Amyloid Deposition in Living Former NFL Players

Detecting CTE in the brains of living individuals could improve our understanding of the disease and inform research regarding prevention and treatment.

Peripartum Neuraxial Analgesia May Not Be Associated With Postpartum MS Relapse

Peripartum neuraxial analgesia may not be associated with an increased risk for multiple sclerosis relapse.

Cognitive Consequences Worse for Pediatric-Onset Multiple Sclerosis

Researchers compared long-term information-processing efficiency between patients with pediatric-onset MS and those with adult-onset MS in a longitudinal cohort study.

Dimethyl Fumarate Makes Lymphocyte Subset Monitoring Unnecessary in Multiple Sclerosis

Dimethyl fumarate induced changes in the multiple sclerosis lymphocyte repertoire, indicating that lymphocyte subset monitoring is not required for safety vigilance.

Model Explores How Statins Alter Multiple Sclerosis Outcomes

Simvastatin’s beneficial effects on clinical outcomes and brain atrophy in patients with multiple sclerosis (MS) are largely independent of cholesterol levels.

FDA to Review Ozanimod for Relapsing Forms of MS

The FDA has accepted for review the New Drug Application (NDA) for ozanimod (Celgene), an investigational treatment for relapsing forms of multiple sclerosis (MS).

Recommendations Developed for Pediatric Multiple Sclerosis Trials

The International Pediatric Multiple Sclerosis Study Group has updated standards for future clinical trials in pediatric multiple sclerosis.

Case Highlights How Symptoms of Cobalamin Deficiency Can Mimic MS

A recently published report describes the case of a 69-year-old female patient with cobalamin deficiency who was mistakenly diagnosed with primary progressive multiple sclerosis (PPMS).

Multiple Sclerosis Flowsheet Deemed Acceptable by Clinicians and Staff

Research shows the Multiple Sclerosis Flowsheet database has demonstrated acceptability among staff and clinicians.

Efficacy of ADS-5102 Extended Release for Impaired Walking in Multiple Sclerosis

The investigators of this Phase 3 study sought to evaluate the efficacy and safety of ADS-5102 (amantadine) extended-release capsules to treat multiple sclerosis patients with walking impairment.